Phase II trial of capecitabine and oxaliplatin in patients with advanced or metastatic pancreatic adenocarcinoma No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results